ASTRAZENECA PLC 13D and 13G filings for Conduit Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 06:00 am Sale |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 73,892 1.100% |
-21,153 (-22.26%) |
Filing |
| 2024-10-11 06:01 am Purchase |
2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 95,045 9.900% |
95,045 (New Position) |
Filing |